Showing 1 - 4 results of 4 for search 'Lais Lopes Almeida Gomes' Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Author
  • Lais Lopes Almeida Gomes
Showing 1 - 4 results of 4 for search 'Lais Lopes Almeida Gomes', query time: 0.01s Refine Results
  1. 1
    The impact of hormones in autoimmune cutaneous diseases

    The impact of hormones in autoimmune cutaneous diseases by Lais Lopes Almeida Gomes, Adrienne J. Werth, Preethi Thomas, Victoria P. Werth

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients

    Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients by Daniella F. Faden, Caroline J. Stone, Lillian Xie, Lais Lopes Almeida Gomes, Victoria P. Werth

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Modern therapy of patients with lupus erythematosus must include appropriate management of their heightened rates of atherosclerotic cardiovascular events: a literature update

    Modern therapy of patients with lupus erythematosus must include appropriate management of their heightened rates of atherosclerotic cardiovascular events: a literature update by Victoria P Werth, Kevin Jon Williams, Lais Lopes Almeida Gomes, Daniella Forman Faden, Lillian Xie, Shae Chambers, Caroline Stone

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study

    Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-... by Caroline J. Stone, Geeta Ahuja, Lais Lopes Almeida Gomes, Joy Poroye, Daniella Forman Faden, Lillian Xie, Rui Feng, Barbara White, Victoria P. Werth

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs